Crossmark

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

Crossref DOI link: https://doi.org/10.1186/s12904-019-0427-4

Published Online: 2019-05-20

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fiorin de Vasconcellos, Vitor

RCC Bonadio, Renata https://orcid.org/0000-0001-5818-922X
Avanço, Guilherme

Negrão, Marcelo Vailati https://orcid.org/0000-0001-8938-6699
Pimenta Riechelmann, Rachel https://orcid.org/0000-0002-0107-9617
License Information

Text and Data Mining valid from 2019-05-20

Version of Record valid from 2019-05-20
More Information

Article History

Received: 17 December 2018

Accepted: 9 May 2019

First Online: 20 May 2019

Ethics approval and consent to participate

: approved by “Comitê de ética em Pesquisa FMUSP” on July, 11 2016.

: not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below